Page last updated: 2024-09-04

atrasentan and acid phosphatase

atrasentan has been researched along with acid phosphatase in 1 studies

Compound Research Comparison

Studies (atrasentan)	Trials (atrasentan)	Recent Studies (post-2010) (atrasentan)	Studies (acid phosphatase)	Trials (acid phosphatase)	Recent Studies (post-2010) (acid phosphatase)
358	41	108	24,029	223	1,701

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Breul, J; Carducci, MA; Daliani, DD; Humerickhouse, RA; Nabulsi, AA; Nelson, JB; Padley, RJ; Schmitt, JL; Schulman, CC; Vogelzang, NJ; Weinberg, MA; Zonnenberg, BA	1

Trials

1 trial(s) available for atrasentan and acid phosphatase

Article	Year
Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Feb-15, Volume: 21, Issue:4 Topics: Acid Phosphatase; Adenocarcinoma; Aged; Antineoplastic Agents; Atrasentan; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Humans; L-Lactate Dehydrogenase; Male; Prostatic Neoplasms; Pyrrolidines; Receptor, Endothelin A; Treatment Outcome	2003

Article

Year

Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Feb-15, Volume: 21, Issue:4

Topics: Acid Phosphatase; Adenocarcinoma; Aged; Antineoplastic Agents; Atrasentan; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Humans; L-Lactate Dehydrogenase; Male; Prostatic Neoplasms; Pyrrolidines; Receptor, Endothelin A; Treatment Outcome

2003